Nabil F. Saba

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (15)

Carlos Chiesa‐Estomba

SPAIN

View details

Andres Coca-Pelaz

Universidad de Salamanca Facultad de Medicina

SPAIN

View details

Antti A. Mäkitie

University of Helsinki

FINLAND

View details

Remco de Bree

NETHERLANDS

View details

Orlando Guntinas-Lichius

Professor and Chairman

Jena University Hospital

GERMANY

View details

Ronald C Eldridge

Assistant Professor

Emory University

UNITED STATES

View details

SHUYUAN HUANG

New York University

UNITED STATES

View details

Loren K. Mell

University of California, San Diego

UNITED STATES

View details

Gyorgy B. Halmos

University Medical Center Groningen

NETHERLANDS

View details

Sandra Nuyts

Katholieke Universiteit Leuven

BELGIUM

View details

Yong Teng

Associate Professor

Emory University

UNITED STATES

View details

Zhaohui Qin

Professor

Emory University

UNITED STATES

View details

Vander Poorten Vincent

BELGIUM

View details

Madelyn Houser

Research Assistant Professor

Emory University

UNITED STATES

View details

Fernando López

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nabil F. Saba

Research Interests

Explore related searches

Contact this professor

Articles (11)

Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy—A Meta-Analysis

Unsupervised Hierarchical Clustering of Head and Neck Cancer Patients by Pre-Treatment Plasma Metabolomics Creates Prognostic Metabolic Subtypes

Adaptive c-Met-PLXDC2 Signaling Axis Mediates Cancer Stem Cell Plasticity to Confer Radioresistance-associated Aggressiveness in Head and Neck Cancer

Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.

Novel Immunotherapeutic Approaches to Treating HPV-Related Head and Neck Cancer

Recurrent Differentiated Thyroid Cancer: The Current Treatment Options

Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline Q and A

Radiomics in Hypopharyngeal Cancer Management: A State-of-the-Art Review

Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer

Longitudinal associations among physical activity, inflammatory markers, and quality of life in patients with head and neck cancer

Immune check point inhibitors in advanced cutaneous squamous cell carcinomas: “Repeat and replicate”

Collaborators (15)

Carlos Chiesa‐Estomba

Andres Coca-Pelaz

Antti A. Mäkitie

Remco de Bree

Orlando Guntinas-Lichius

Ronald C Eldridge

SHUYUAN HUANG

Loren K. Mell

Gyorgy B. Halmos

Sandra Nuyts

Yong Teng

Zhaohui Qin

Vander Poorten Vincent

Madelyn Houser

Fernando López

Make your next move.